ivonescimab

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  

ivonescimab
Sep 30, 2024, 08:39 | Opinion
Tanja Obradovic: Strategy of clinical development in oncology requires global considerations
Tanja Obradovic shared the following on LinkedIn: “Strategy of clinical development in oncology always encompasses…
Sep 29, 2024, 06:34 | Insight
Picks from Lung Cancer Cocktail With Science by Stephen V Liu
The Lung Cancer Cocktail With Science 2024 conference took place on September 27th in Milan,…
Sep 25, 2024, 18:29 | Insight
Tanja Obradovic: Ligufalimab plus ivonescimab combined with chemo in the first-line CRC patients
Tanja Obradovic shared a post on LinkedIn: "Tackling large medical need in microsatellite stable (MSS)…
Sep 14, 2024, 12:01 | Blog
Zhen Su: Phase III NSCLC results are out – Ivonescimab vs. Pembrolizumab!
Zhen Su, CEO at Marengo Therapeutics, posted the following on LinkedIn: “Phase III NSCLC Ivonescimab (Anti-VEGF/PD-1…
Sep 13, 2024, 10:46 | Blog
Chris De Savi: Breaking News from WCLC24
Chris De Savi shared a post on LinkedIn: ''Ivonescimab Outshines Keytruda in 1st Line Lung…
Sep 11, 2024, 13:54 | Blog
Noemi Reguart: Presidential Phase 3, Ivonescimab vs Pembrolizumab for PD-L1+ advanced NSCLC
Noemi Reguart shared a post on X: ''WCLC24 Presidential. Phase 3 Ivonescimab (AK112) versus Pembrolizumab…
Sep 10, 2024, 13:45 | Societies
Rami Manochakian's key highlights from WCLC24
WCLC is a major international event focused on the latest advancements in lung cancer research,…
Sep 9, 2024, 09:04 | Societies
Insights from WCLC24: Ana I. Velázquez Mañana’s Key Highlights
The WCLC24 is taking place at the San Diego Convention Center from September 7 to…
Aug 14, 2024, 13:49 | Insight
Amol Akhade: New and exciting data coming up at WLCC 24
Amol Akhade shared on X about recent papers: "What's new and exciting data coming up…
Aug 12, 2024, 14:02 | Blog
Stephen Liu: WCLC24 abstract titles released
Stephen Liu shared a post on X: "WCLC24 abstract titles released! Don't miss the plenary…
Jun 1, 2024, 10:17 | Blog
Hidehito Horinouchi: HARMONi-A - Chemo +/- Ivonescimab in EGFRm NSCLC after EGFR-TKIs resistance
Hidehito Horinouchi, Oncologist at the Department of Thoracic Oncology at the National Cancer Center Hospital,…
May 29, 2024, 09:22 | Blog
Eric K. Singhi: Isn’t it about time we stopped saying that "patients failed treatment"
Eric K. Singhi reshared his previous post on X and added:       ; "But…
May 27, 2024, 13:04 | Insight
Gilberto Lopes: Few of the positive trials we have data for in lung cancer from ASCO24
Gilberto Lopes, Chief of the Division of Medical Oncology at Sylvester Comprehensive Cancer Center, shared a…
May 27, 2024, 04:19 | Opinion
Gilberto Lopes: My top ASCO24 lung cancer abstracts!
Gilberto Lopes, Chief of the Division of Medical Oncology at Sylvester Comprehensive Cancer Center, shared…
All: 14 Posts: 1 - 100
Special Coverage